<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">136771</id>
  <title nil="true"/>
  <common-name>Tarloxotinib</common-name>
  <description>Tarloxotinib is an organoheterocyclic compound with the formula C24H24BrClN9O3. Tarloxotinib belongs to the pyrido[3,4-d]pyrimidines, a subclass of pyridopyrimidines within the organic compounds. With an average molecular weight of 601.87 g/mol, Tarloxotinib is a heavy molecule. This compound acts as an inhibitor of two recorded protein targets: the epidermal growth factor receptor (EGFR) and the receptor tyrosine-protein kinase erbB-2 (ERBB2).</description>
  <cas>1636938-13-0</cas>
  <pubchem-id>51038316</pubchem-id>
  <chemical-formula>C24H24BrClN9O3</chemical-formula>
  <weight>601.9</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-14T20:01:12Z</created-at>
  <updated-at type="dateTime">2026-08-22T03:06:08Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB14944</drugbank-id>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CN1C=NC(=C1C[N+](C)(C)C\C=C\C(=O)NC1=NC=C2N=CN=C(NC3=CC(Br)=C(Cl)C=C3)C2=C1)[N+]([O-])=O</moldb-smiles>
  <moldb-formula>C24H24BrClN9O3</moldb-formula>
  <moldb-inchi>InChI=1S/C24H23BrClN9O3/c1-33-14-30-24(34(37)38)20(33)12-35(2,3)8-4-5-22(36)32-21-10-16-19(11-27-21)28-13-29-23(16)31-15-6-7-18(26)17(25)9-15/h4-7,9-11,13-14H,8,12H2,1-3H3,(H-,27,28,29,31,32,36)/p+1/b5-4+</moldb-inchi>
  <moldb-inchikey>MUJMYVFVAWFUJL-SNAWJCMRSA-O</moldb-inchikey>
  <moldb-average-mass type="decimal">601.87</moldb-average-mass>
  <moldb-mono-mass type="decimal">600.086853</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>0.14</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM132664</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>[(2E)-3-({4-[(3-bromo-4-chlorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl}carbamoyl)prop-2-en-1-yl]dimethyl[(1-methyl-4-nitro-1H-imidazol-5-yl)methyl]azanium</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Pyridopyrimidines</klass>
  <subklass>Pyrido[3,4-d]pyrimidines</subklass>
  <paper-count type="integer">191</paper-count>
  <sync-id>CED0015505</sync-id>
  <structure-inchikey>MUJMYVFVAWFUJL-SNAWJCMRSA-O</structure-inchikey>
  <structure-fingerprint>100000000000084000000100000000000000000010000000000000000000000000000000000400000000200200000000200000000000000000050000000080000000044000000000000000a0000200020001002000810008000004000000000202100000142100000001000800000040009000000000000000000014000800000480000000050000000000040860000040010008000200000000000000001000000000000000c8100080000004000000000080000000000002204000100000000000000000000000100000000000010000000000008000200000000000000208000100000000040040000000600000000001000002000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKQAAAIABBgBgAAAAAQMHQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:50:06Z</structure-indexed-at>
</compound>
